Cryo-Cell Income After Taxes 2010-2024 | CCEL

Cryo-Cell income after taxes from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.

Cryo-Cell Income After Taxes 2010-2024 | CCEL

Cryo-Cell income after taxes from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
Related Stocks
Company NameMarket
Cap
Elevance Health (ELV)$95.8B
Cencora (COR)$49B
DiDi Global (DIDIY)$23.3B
ICON (ICLR)$17.5B
Natera (NTRA)$16.7B
Viatris (VTRS)$15.4B
Avantor (AVTR)$14.8B
Revvity (RVTY)$14.6B
BioMerieux (BMXMF)$12.9B
CochLear (CHEOY)$12.7B
Solventum (SOLV)$12.2B
Medpace Holdings (MEDP)$11.2B
Charles River Laboratories (CRL)$11B
Doximity (DOCS)$10.8B
HealthEquity (HQY)$8.7B
Sonic Healthcare (SKHHY)$8.5B
Bausch + Lomb (BLCO)$6.9B
Life Times (LTH)$5B
Sotera Health (SHC)$4.4B
Organon (OGN)$4B
Surgery Partners (SGRY)$3.8B
BrightSpring Health Services (BTSG)$3.4B
PACS (PACS)$3.1B
Concentras Parent (CON)$2.6B
Alignment Healthcare (ALHC)$2.5B
Ardent Health Partners (ARDT)$2.4B
Premier (PINC)$2.3B
GeneDx Holdings (WGS)$2.1B
Ryman Healthcare (RYHTY)$2B
GoodRx Holdings (GDRX)$1.8B